At ViVE 2026, MedCity News sat down with Richard Queen, Chief Technology Officer at Sellers Dorsey, to discuss a shift happening quietly, but meaningfully, inside Medicaid programs across the country.
The conversation wasn’t about flashy AI headlines or experimental technology. It was something far more consequential: how analytics, when embedded into policy and program design, can actually change outcomes.
Watch the interview below.
For Sellers Dorsey, analytics are not the product. They are the enabler.
“Our mission is to increase access, quality, and outcomes for vulnerable populations,” Queen explained. “That means analytics can’t just sit in a dashboard. They must connect directly to the levers that drive change.”
Those levers are tangible… State plan amendments. Directed payment programs. Quality incentive design. Risk oversight. Value-based care implementation. The difference lies in how data inform policy and program design so that leaders can see not only how they’re performing, but what to do next.
That is the role of Constyn, Sellers Dorsey’s technology platform. Rather than simply reporting performance, Constyn helps health systems, payers, and providers turn insight into action by embedding analytics into the design and operationalization of care delivery. The goal isn’t just visibility. It’s also clarity for decision support around which actions will move the needle and having the measurable proof that they did.
